Search for: "FOREST PRODUCTS V US" Results 181 - 200 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs)   General Blockbusters and other strategies (IP Think Tank) AU - TRIPS, Pharmaceuticals and Manufacture for Export - IP Think Tank Podcast (IP Think Tank) Germany: Open fight on biotechnology, patents, and CIIs (IP Jur) US - It’s not an invention if you use conventional techniques to make it (Patent Baristas) US - Debate on creating a regulatory pathway for approval of follow-on biologics (FOB)… [read post]
17 Jan 2013, 1:05 pm by Rebecca Tushnet
  And the Pom entities “could use similar marketing techniques to make disease claims about other food products, including the other food products Respondents currently sell. [read post]
12 May 2016, 6:14 pm by Jason Rantanen
One need only reflect on the fact that more than 1,000 qui tam actions for false marking were filed by opportunistic plaintiffs following the 2009 Federal Circuit decision in Forest Group, Inc. v. [read post]
27 Feb 2009, 5:00 am
(Patent Baristas) US: Teva releases second video in year of affordable healthcare campaign (SmartBrief) US: Discussion of NYT article ‘Crop Scientists Say Biotechnology Seed Companies are Thwarting Research’ (Patent Docs) (Patent Baristas) US FDA: Genetically engineered organisms can be patented (RelatIP) US: Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo seeks review and correction of patent term adjustment for patent covering… [read post]
5 Apr 2007, 5:39 am
In giving credence to this argument, courts have stretched a small regulatory exception for emergency situations beyond recognition, and use it to swallow the general rule - that warnings on FDA-regulatory products are subject to prior FDA review and approval. [read post]
8 Oct 2009, 6:05 am
 Have the inventor make a secret side deal (Patent Baristas) US: Governors send letter to Congressional leaders in support of 12-year data exclusivity period (Patent Docs) US Congress urged to act on biosimilars (GenericsWeb) US: Hal Wegner wakes up ACI Biotech Patents Forum in Boston – KSR and biotech claims (BioTechnology Patent Law)   Products Amrix (Cyclobenzaprine) – US: Eurand files patent infringement suit in C… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to… [read post]
12 Jul 2016, 12:13 am by Eleonora Rosati
 Nearly a decade later, the US Supreme Court in Qualitex Co v Jacobson Products Co, Inc, held that there existed no objection to the use of color alone as a trade mark, when the colour has attained a secondary meaning and therefore identifies and distinguishes a particular brand. [read post]
27 Jun 2008, 10:45 am
As the District Court for the District of Columbia put it while granting summary judgment to the government in American Forest Research Council v. [read post]
24 Sep 2015, 5:24 am
Ct. 2466 (2013), can provide the basis for using this type of preemption in certain cases involving medical devices cleared under the FDCA’s §510(k) “substantial equivalence” process. [read post]
6 Aug 2013, 11:15 am by Shafik Bhalloo
Apollo Forest Products Ltd.[2], the province’s Supreme Court considered a wrongful dismissal action brought by Marvin McLennan, a former “bin chaser” at a sawmill. [read post]